DBV Technologies logo

DBV Technologies

DBVT | NASDAQ
Chart Builder DCF Calculator
$10.27
-$0.75 (-6.76%)
At close: Nov 16, 2026, 4:00 PM ET
$10.27
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET
-6.76%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
28
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #851/1021 (Top 83%)

Key Statistics

Market Data

Market Cap $245.68M
1D Range
10.20 10.91
52W Range
8.87 24.54

Valuation (TTM)

PE -4.37
PB 1.65
EV/EBITDA -0.51

Valuation (NTM)

Forward PE N/A
Forward PEG 0.18
Price Target $48.00
Loading financial charts...

Profile

DBV Technologies S.A., a biopharmaceutical firm based in Montrouge, France, operates at the clinical stage, focusing on the research and development of epicutaneous immunotherapy solutions. Its flagsh...

Sector Healthcare
Industry Biotechnology
Employees 125
IPO Date Oct 22, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 28, 2026
EPS
-$0.7
Miss -16.67%
REV
$1.79M
Beat +220.00%
Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$48.00
Upside
+367.38%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.